Inactive

12 Feb 21 - The due date for technology submission has been extended to 5 Mar 21. Title: Dry Decontaminate for Patient/Casualty Decontamination Technology Call 1. The Maneuver Support Center of Excell... 12 Feb 21 - The due date for technology submission has been extended to 5 Mar 21. Title: Dry Decontaminate for Patient/Casualty Decontamination Technology Call 1. The Maneuver Support Center of Excellence (MSCoE) Homeland Defense Civil Support Office (HDCSO) seeks dry (waterless/limited water) decontamination technology capabilities from industry and government sources. Preference will be given to wet wipe type solutions, carbon-based microfiber membrane wipes but other technologies, i.e. High-Efficiency Particulate Air (HEPA) Filter vacuums, will also be considered. Capabilities will consist of a white paper and quad chart using the attached templates as guides. The completed packets should be submitted via email to curtis.r.ratliff.civ@mail.mil NLT 15 February 2021. Submission of additional material, i.e. product data sheets, is permissible. 2. Background. The MSCoE HDCSO develops capabilities and provides training to improve the Army's effectiveness for operations in the Homeland. Included in our responsibilities is the requirement to develop capabilities and processes to conduct mass casualty decontamination and patient decontamination. A history of experimentation and training exercises has shown that we need an improved means of conducting these functions. Current procedures require an immense amount of water, which isn’t always available. If access to sufficient amounts of water is available then there is a subsequent responsibility for collection and potential treatment of the effluent to ensure untreated contaminated water isn’t released back into the environment. 3. Concept of the Operation. The MSCoE HDCSO will conduct a three phase assessment of dry decontamination technologies that are suitable for use on humans, in Fiscal Year 21 and 22. a. Phase I will consist of an operational assessment of selected technologies to determine visible reduction to decontaminated persons with radiological particle contamination. Vendors will utilize their technology in the prescribed dry decon method to decontaminate visually "contaminated" dummies. Observers will assess the level of removal of the contamination, as well as, ease of use, potential logistical impact (e.g. does it require electricity, transportable, storage impact), ability to conduct the performed operation within the prescribed times (Ambulatory - less than 3 minutes; non-Ambulatory - less than 9 minutes), ruggedized, and observers' advantages and disadvantages. Each technology will go through a number of iterations. b. Phase II is a technical laboratory experiment of selected technologies to determine percent reduction of radiological particle contamination at three operating temperatures. c. Phase III will include the use of promising technologies in a large scale training exercise, Arctic Eagle 22, to assess procedures and impact on resources. 4. Timeline. The milestones this effort are outlined below. All dates are projected and may shift. a. 15 February 2021 - Technology submissions due. b. 12 – 19 February 2021 - Technology submissions reviewed. c. 24 February 2021 - Technology selection results finalized. d. 1 March 2021 – Dry decon procedures provided to selected vendors e. June 2021 – Phase I* Execution f. July 2021 – Determination of Phase II technologies g. September 2021 – Phase II* Execution - Laboratory Tech Experiment h. February 2022 – Phase III Execution 5. Learning Demands. Proposed and selected technologies will be evaluated based on their ability to address the following learning demands: a. What capabilities are available to conduct waterless / limited water patient /casualty decontamination? b. Does capability reduce particle contamination at operating temperatures (above 64 °F, around freezing 32 - 35° F, cold weather - 5° F )? c. Does capability decontaminate ambulatory casualties in less than three minutes and non-ambulatory casualties less than nine minutes from time of arrival to time of release? d. Does capability decontaminate personnel through technical decontamination at a rate of greater than eight personnel per hour? e. Does capability decontaminate contaminated human remains (CHR) in less than 90 minutes from time of arrival to time of release? f. Will the system require large amount of resource support to operate and maintain? g. What is the cost of the capability per casualty? 6. Submission Point of Contact. The point of contact for all technology submissions and questions pertaining to the selection process is Mr. Curtis Ratliff, MSCoE HDCSO, Fort Leonard Wood, MO at (573)563-6294 or curtis.r.ratliff.civ@mail.mil.